Foresee Pharmaceuticals (6576.TWO) Earnings Analysis
Foresee Pharmaceuticals (6576.TWO) next reports earnings on 2026-08-19. Last quarter (2026-03-13) it missed with EPS -0.92 TWD vs -0.57 TWD est (-61.4%). It has beaten estimates in 1/3 recent quarters (33%). Trailing P/E -68.60.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6576.TWO next report earnings?
| Next earnings date | 2026-08-19 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
6576.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-13 | -0.92 TWD | -0.57 TWD | -61.4% | Miss |
| 2025-03-13 | -3.52 TWD | -1.45 TWD | -142.8% | Miss |
| 2024-08-14 | -1.21 TWD | -1.4 TWD | +13.6% | Beat |
Beat rate: 1/3 (33%) over reported quarters with consensus data.
6576.TWO valuation and analyst view
| Trailing P/E | -68.60 |
|---|---|
| Trailing EPS | -1.16562 TWD |
| Price / book | 9.35 |
| Dividend yield | 0.00% |
| Market cap | 13.08B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Foresee Pharmaceuticals (6576.TWO)'s next earnings date?
Foresee Pharmaceuticals is next scheduled to report on 2026-08-19.
Did 6576.TWO beat earnings last quarter?
In its 2026-03-13 report, 6576.TWO posted EPS of -0.92 TWD versus a -0.57 TWD estimate — a miss of 61.4%.
What is 6576.TWO's earnings track record?
Over the last 3 reported quarters with consensus data, 6576.TWO beat estimates 1 times (33%).
What is 6576.TWO's current P/E ratio and EPS?
6576.TWO trades at a trailing P/E of -68.60 on trailing EPS of -1.1656196495515967 TWD.
What do analysts rate 6576.TWO?
6576.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.